DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20185128

A study on management of maternal anemia with infusion of intravenous iron sucrose and its outcome in management of anemia

Uma Maheswari R., R. Veerakumaran

Abstract


Background: In India, women become pregnant with low baseline hemoglobin level resulting in high incidence of moderate to severe anemia in pregnancy where oral iron therapy cannot meet the requirement. Pregnant women with moderate anemia are to be treated with parenteral iron therapy. The aim of the study is to the infusion of intravenous iron sucrose and its outcome in the management of anemia.

Methods: Totally 100 pregnant females were included in the study. The study period was from January 2018-July 2018 at vanavil medical center in Chennai. 50 Patients of Group A was given oral iron tablets containing100mg of elemental iron. 50 patients of Group B was given a total of 1000 mg of intravenous iron sucrose divided into five doses of 200 mg each at weekly intervals. Estimation of hemoglobin was started 4 weeks after commencement of iron therapy and then repeated every 4 weeks till 36 weeks of gestation, pre-delivery and postpartum.

Results: Target hemoglobin levels were achieved in 4 weeks’ time in 19 (76%) patients in the iron sucrose group as compared to 08 (32%) of patients in the oral iron group. There was a significant improvement in the various hematological parameters in iv sucrose group as compared to patients in the oral iron group. There were no significant allergic reactions in iv sucrose group.

Conclusions: Our results showed that intravenous iron sucrose therapy was effective to treat moderate anemia in pregnant women. Intramuscular preparations are known to be associated with local side-effects. Iron sucrose complex iv therapy was with negligible side effects. It caused a rapid rise in hemoglobin level and the replacement of stores was faster. Long term comparative studies are required to assess if they can be used at a peripheral level.


Keywords


Anaemia, Intravenous sucrose, Parenteral iron therapy, Pregnant women

Full Text:

PDF

References


Kriplani A, Mahey R, Dash BB, Kulshreshta V, Agarwal N, Bhatla N. Intravenous iron sucrose therapy for moderate to severe anemia in pregnancy. Indian J Med Res. 2013;138(1):78-82.

Al-Momen AK, Al-Meshari A, Al-Nuaim L, Saddique A, Abotalib Z, Khashogji T. Intravenous iron sucrose complex in treatment of iron deficiency anemia during pregnancy. Euro J Obstet Gynaecol Reprod Biol.2006;69(2):121-4.

Auerbach M, Witt D, Toler W, Fierstein M, Lerner RG, Ballard H. Clinical use of the total dose intravenous infusion of iron dextran. J Lab Clinic Med. 1988;111(5):560-5.

Bailie GR, Clark JA, Lane CE, Lane PL. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant. 2005;20(7):1443-9.

Bashiri A, Burstein E, Sheiner E, Mazor M. Anaemia during Pregnancy and treatment with intravenous iron: review of the literature. Eur J Obstet Gynecol Reprod Biol. 2003;110(1):2-7.

Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Europ J Obstet Gynecol Reprod Biol. 2005;123:S15-9.

Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route. Am J Obstet Gynecol. 2002;186 (3):518-22.

Bencaiova G. Iron prophylaxis in pregnancy. Intravenous iron verses oral route. Eur J Obstet Gynecol Reprod Biol. 2009;144(2):135-9.

Bhandari N, Russel R. Intravenous versus oral iron therapy in postpartum anemia. BJOC. 2006; 113(11):1248-52.

Breyman C. The use of iron sucrose complex for anemia in pregnancy and postpartum period. Semen Hematology. 2006;43:S28-31.

Bhatt RV, Joshi SK, Shah MC, Total dose intravenous infusion of iron-dextran (imferon) in severe anemia. Am J Obstet Gynecol 2006. 94(8):1098-102.

Litton E, JXiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing the requirement of allogenic blood transfusions. Systematic review and meta-analysis of RCT. BMJ. 2013;347:4822.

Ezzati M, Lopus AD, Dodgers A, Vander HS, Murray C. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347-60.

Christoph P, Schuller C, Studer H, Irion O, De Tejada BM, Surbek D. IV iron treatment in pregnancy; comparison of high dose ferric carboxy maltose Vs iron sucrose. J Perinat Med. 2012;40(5):469-74.

Hallak M, Sharon A, Duckman R, Auslender R, Abramovici. Supplementing iron intravenously in pregnancy. A way to avoid blood transfusions. J Reprod Med. 1997;42(11):99-103

KalaivaniK, Prevalence and consequences of anemia in pregnancy. Indian J Med. Res. 2009:130(5);627-33.

Krafft A, Perewusnyk G, Hänseler E, Quack K, Huch R, Breymann C. Effect of postpartum iron supplementation on red cell and iron parameters in nonanaemic iron-deficient women: a randomized placebo-controlled study. BJOG. 2005;112(4):445-50.

Mahomed K. Iron and folate supplementation in pregnancy. In the Cochrane library; Oxford update. 2002:90(2):167-9

Milman N, Bergholt T, Byg K, Erikson L, Graudal N. Iron status and iron balance during pregnancy, a critical reappraisal of iron supplementation. Acta Obstet Gynecol Scand. 1999;78(9):749-57.

Momen AK, Meshari A, Nuaim L, Saddique A, Abotalib Z, Khashogji T, et al. Intravenous iron sucrose in the treatment of iron deficiency anemia during pregnancy. Reprod boil.1996;69(2):121-4.

Perewusnyk G., Huch R., Huch A., Breymann C. — Parenteral iron therapy in obstetrics: 8 years’ experience with the iron-sucrose complex. Br J Nutr.2009;88(1):3-10.

Rohilla M, Raveendran A, Dhaliwal LK, Chopra S. Severe anemia in pregnancy: a tertiary hospital experience from northern India. J. Obstet Gynecol. 2010;30(7):694-6.

Robinson C., Bell DN, Sturdy JH, A Possible association of malignant neoplasm with iron dextran injection. Br Med J. 2010;2(5199):648-50.